2003
DOI: 10.1097/00000658-200303000-00018
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: DNA microarray technology will help identify molecular changes that can serve as targets for new therapies to attenuate muscle wasting in severely burned children and thus improve recovery and early rehabilitation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…50nM of insulin treatment improved myotube fusion and creatine kinase activity in C2C12 cell lines through NF-κB/MAPKs pathways (33). Oxandrolone administration was shown to increase muscle myogenesis with MRF4 gene expression action in pediatric burn patients (34). These data provide fundamental evidence to link tissue metabolic status and cellular homeostasis in response to severe injury.…”
Section: Discussionmentioning
confidence: 99%
“…50nM of insulin treatment improved myotube fusion and creatine kinase activity in C2C12 cell lines through NF-κB/MAPKs pathways (33). Oxandrolone administration was shown to increase muscle myogenesis with MRF4 gene expression action in pediatric burn patients (34). These data provide fundamental evidence to link tissue metabolic status and cellular homeostasis in response to severe injury.…”
Section: Discussionmentioning
confidence: 99%
“…Oxandrolone administered at 0.1 mg/kg twice daily has been shown to enhance protein synthesis and upregulate anabolic genes in acute pediatric burn patients [160], and similarbenefits have also been demonstrated in adult patients [161]. Long-term benefits include increased bone mineral density and LBM up to 12 months post burn [161].…”
Section: Clinical Managementmentioning
confidence: 99%
“…Oxandrolone has been used in acute and rehabilitating adult burn patients with promising results with regard to weight gain, net protein synthesis in the muscle, and LBM [65, 66]. When treated orally with 0.1 mg/kg oxandrolone twice daily, acute pediatric burn patients exhibit enhanced protein anabolism and upregulation of anabolic genes in the muscle [67, 68]. Oxandrolone affects LBM and bone mineral density not only in the acute setting, but also up to 12 months post burn [68].…”
Section: Current Therapies Administered To Counteract Specific Aspmentioning
confidence: 99%